Digoxin Injection Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Digoxin Injection is a cardiovascular injectable medicine used for heart failure management, atrial fibrillation treatment, and rapid cardiac rate control in hospital and critical care settings.

The formulation contains Digoxin, a cardiac glycoside that helps improve cardiac contractility while slowing atrioventricular conduction, supporting better heart pumping efficiency and controlled ventricular rate management in cardiac patients.

Genliva Wellness LLP manufactures these formulations as a Digoxin Injection Manufacturer in India, while also serving as a Cardiac Glycoside Injection Exporter and Heart Failure Injectable Medicine Supplier for hospital procurement systems, cardiology departments, and regulated international healthcare markets.

Digoxin Injection is formulated for cardiac rhythm and heart failure management.

Sterile cardiac glycoside injectable formulation
Frequently utilized in atrial fibrillation management
Supports cardiac contractility improvement therapies
Helps regulate ventricular heart rate control

This formulation is prescribed in cardiovascular management therapies.

Treatment of congestive heart failure
Management of atrial fibrillation conditions
Administered in cardiac rhythm control therapies
Utilized in emergency cardiovascular care protocols

Digoxin Injection delivers cardiac support therapy for cardiovascular stabilization.

Valuable in heart failure management
Frequently preferred in atrial fibrillation care
Effective injectable cardiac rhythm support
Useful in hospital cardiovascular treatment
Reliable sterile cardiac administration
Maintains dependable cardiovascular therapeutic performance